Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS

Clinical trial NCT07616037 · RECRUITING

Trial details

NCT number: NCT07616037
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

PCOS (Polycystic Ovary Syndrome)

Start date: 2026-06-01
Primary completion: 2027-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.